Prologis, Inc.
$163.40B- Market cap
- $129.51B
- Debt
- +$35.04B
- Cash
- −$1.15B
Capital structure 79% equity / 21% debt · EV / Revenue 18.59x · EV / EBITDA 30.22x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: PLD stock price at discount vs CSGP $138.91 current versus $5.41K implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CSGP's multiple
Implied fair value · at PLD's multiple
Snapshot Sep 8, 2026, 3:44 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: PLD FY 2025 (ended Dec 31, 2025) · CSGP FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 79% equity / 21% debt · EV / Revenue 18.59x · EV / EBITDA 30.22x
Capital structure 99% equity / 1% debt · EV / Revenue 3.33x · EV / EBITDA 44.35x
PLD carries the larger enterprise value at $163.40B against $10.82B; CSGP trades on the lower EV / Revenue multiple (3.33x vs 18.59x); PLD on the lower EV / EBITDA (30.22x vs 44.35x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Prologis, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
COSTAR GROUP, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.66x
0.02x
Net debt / EBITDA
Leverage against operating earnings
6.27x
-6.12x
Cash and equivalents
Liquid reserves on the balance sheet
$1.15B
$1.63B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$35.04B
$140.00M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe PLD can sustain its 49.6% operating margin and 37.9% net margin while closing the gap to the upper end of its historical band, then hold or add to PLD; otherwise avoid relying on the extreme P/E-implied upside because the DCF range and CSGP multiples do not support it.
The implied price of $5,345.34 from the P/E framework is wildly detached from the current PLD price of $144.15 and from both the historical band and DCF range. Relative to CSGP, PLD trades on a much lower P/E, but its EV/Revenue and EV/EBITDA are substantially richer, showing that the valuation picture is mixed rather than a clear discount.
Supporting Metrics